Q301--Notice of Intent to Sole Source - Pathology Reference Lab Services - 528,528A8

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

• Oct 1, 2026LABORATORY CORPORATION$1.3MQ301--CYTOPATHOLOGY AND NEXT GENERATION SEQUENCING TESTING SERVICESNo listed company matched (Materiality N/A)
• Jun 30, 2026LABORATORY CORPORATION$2.4MEMERGENCY BRIDGE- Downstate Reference LabNo listed company matched (Materiality N/A)
• Jun 24, 2026QUEST DIAGNOSTICS INCORPORATED$675KQ301--V797D-70090 | 36C24226A0046 | URGENT Bridge Specialized Genetic and Esoteric Lab Testing FSS-BPA LSJ AttachedMateriality: <0.01% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $675K award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC
• Jun 1, 2026THE ROGOSIN INSTITUTE INC$391KQ301--Tissue Typing and Immunogenetics Lab ServicesNo listed company matched (Materiality N/A)
• Jun 1, 2026THE ROGOSIN INSTITUTE INC$2.0MQ301--Tissue Typing and Immunogenetics Lab ServicesNo listed company matched (Materiality N/A)
• Apr 1, 2026Eurofins Transplant Genomics, LLC$600KQ301--DONOR-DERIVED CELL FREE DNA TESTINGNo listed company matched (Materiality N/A)
• Dec 4, 2025QUEST DIAGNOSTICS INCORPORATED$6.8MQ301--Base-Reference Laboratory Testing for VISN2 North (VA-26-00003512)Materiality: 0.06% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $6.8M award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC
• Jun 23, 2025QUEST DIAGNOSTICS INCORPORATED$655KQ301--6-Month Bridge VISN 2 South Specialized Genetic and Esoteric Lab Testing FSS-BPA LSJ AttachedMateriality: <0.01% of $DGX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $655K award ÷ $11.8B revenue, 12 months to Sep 30, 2026 (SEC 10-Q). SEC

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.